Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:AAWH OTCMKTS:ALIOF OTCMKTS:CHUCD OTCMKTS:STDAF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAAWHAscend Wellness$0.45-9.3%$0.53$0.26▼$1.20$99.62M1.1999,526 shs94,092 shsALIOFALIOF$278.50$278.50$138.01▼$286.30$29.89BN/A924 shsN/ACHUCDCharlie's$0.24+2.1%$0.25$0.16▼$4.69$48.76M5.57250,570 shs25,604 shsSTDAFSTADA Arzneimittel Aktiengesellschaft$110.42$110.42$75.15▼$115.00$6.88B0.38180 shsN/AThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAAWHAscend Wellness-9.34%-16.04%-16.57%-5.00%+52.39%ALIOFALIOF0.00%0.00%0.00%0.00%0.00%CHUCDCharlie's+2.13%+9.14%-4.04%-17.24%+166.37%STDAFSTADA Arzneimittel Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAAWHAscend Wellness$0.45-9.3%$0.53$0.26▼$1.20$99.62M1.1999,526 shs94,092 shsALIOFALIOF$278.50$278.50$138.01▼$286.30$29.89BN/A924 shsN/ACHUCDCharlie's$0.24+2.1%$0.25$0.16▼$4.69$48.76M5.57250,570 shs25,604 shsSTDAFSTADA Arzneimittel Aktiengesellschaft$110.42$110.42$75.15▼$115.00$6.88B0.38180 shsN/AThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAAWHAscend Wellness-9.34%-16.04%-16.57%-5.00%+52.39%ALIOFALIOF0.00%0.00%0.00%0.00%0.00%CHUCDCharlie's+2.13%+9.14%-4.04%-17.24%+166.37%STDAFSTADA Arzneimittel Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAAWHAscend Wellness 2.00HoldN/AN/AALIOFALIOF 0.00N/AN/AN/ACHUCDCharlie's 0.00N/AN/AN/ASTDAFSTADA Arzneimittel Aktiengesellschaft 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ALIOF, STDAF, AAWH, and CHUCD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/12/2026AAWHAscend Wellness Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold3/26/2026AAWHAscend Wellness Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell(Data available from 6/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAAWHAscend Wellness$500.58M0.18N/AN/A($0.23) per share-1.94ALIOFALIOFN/AN/AN/AN/AN/AN/ACHUCDCharlie's$16.69M2.92N/AN/A($0.03) per share-8.00STDAFSTADA Arzneimittel Aktiengesellschaft$3.84B1.79$11.12 per share9.93$23.11 per share4.78Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAAWHAscend Wellness-$118.19M-$0.64N/AN/AN/A-26.24%-1,099.51%-12.44%N/AALIOFALIOFN/AN/AN/AN/AN/AN/AN/AN/AN/ACHUCDCharlie's-$7.19MN/AN/AN/AN/A-140.60%N/A-327.67%N/ASTDAFSTADA Arzneimittel Aktiengesellschaft$292.15MN/AN/AN/AN/AN/AN/AN/AN/ALatest ALIOF, STDAF, AAWH, and CHUCD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026AAWHAscend Wellness-$0.13-$0.15-$0.02-$0.15N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAAWHAscend WellnessN/AN/AN/AN/AN/AALIOFALIOFN/AN/AN/AN/AN/ACHUCDCharlie'sN/AN/AN/AN/AN/ASTDAFSTADA Arzneimittel AktiengesellschaftN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAAWHAscend Wellness133.342.141.15ALIOFALIOFN/AN/AN/ACHUCDCharlie'sN/A0.220.17STDAFSTADA Arzneimittel Aktiengesellschaft2.231.540.99Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAAWHAscend Wellness17.31%ALIOFALIOFN/ACHUCDCharlie's3.11%STDAFSTADA Arzneimittel AktiengesellschaftN/AInsider OwnershipCompanyInsider OwnershipAAWHAscend Wellness21.64%ALIOFALIOFN/ACHUCDCharlie's74.80%STDAFSTADA Arzneimittel AktiengesellschaftN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAAWHAscend Wellness2,300202.27 million158.50 millionNot OptionableALIOFALIOFN/A107.33 millionN/ANot OptionableCHUCDCharlie's45203.17 millionN/ANot OptionableSTDAFSTADA Arzneimittel Aktiengesellschaft12,50062.34 millionN/ANot OptionableALIOF, STDAF, AAWH, and CHUCD HeadlinesRecent News About These CompaniesStada Arzneimittel AG Registered Shares (STDAF)April 9, 2026 | nasdaq.comFor Faculty & StaffOctober 9, 2024 | smith.eduSChicago's GTCR in advanced talks to acquire German drugmakerSeptember 10, 2024 | chicagobusiness.comCTrump calls his former chief of staff a ‘terrible, stupid person’August 29, 2024 | msnbc.comMStada CEO confirms company may be for saleAugust 6, 2024 | pharmaphorum.comPThis week’s deal pipeline: Bain and Cinven consider IPO option for Stada ArzneimittelMay 18, 2024 | penews.comPAJMC StaffMay 8, 2024 | ajmc.comAWDBJ7 StaffApril 22, 2024 | wdbj7.comWSTAFF NEWSFebruary 22, 2024 | washingtonpost.comKPLUY K+S AktiengesellschaftJanuary 10, 2024 | seekingalpha.comKPLUY K+S AktiengesellschaftJanuary 10, 2024 | seekingalpha.comPopSci StaffNovember 23, 2023 | popsci.comPBrighton and Hove council staff to receive more moneySeptember 26, 2023 | theargus.co.ukTNCR Editorial StaffSeptember 19, 2023 | ncronline.orgNStaff SenateAugust 11, 2023 | uwyo.eduUSTADA Arzneimittel AG V (SAZA)July 21, 2023 | investing.comWhy are flags at half-staff today in Wisconsin?June 10, 2023 | jsonline.comJCBI hired 'toxic' staff and failed to sack offendersMay 30, 2023 | bbc.co.ukWTVY StaffMay 13, 2023 | wtvy.comWStaff EditorialsApril 15, 2023 | thegazette.comTNew MarketBeat Followers Over TimeMedia Sentiment Over TimeALIOF, STDAF, AAWH, and CHUCD Company DescriptionsAscend Wellness OTCMKTS:AAWH$0.45 -0.05 (-9.34%) As of 06/23/2026 03:59 PM EasternAscend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores. Ascend Wellness Holdings, Inc. was incorporated in 2018 and is headquartered in New York, New York.ALIOF OTCMKTS:ALIOF$278.50 0.00 (0.00%) As of 09/27/2022Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland.Charlie's OTCMKTS:CHUCD$0.24 +0.01 (+2.13%) As of 06/22/2026Charlie's Holdings, Inc., together with its subsidiaries, formulates, markets, and distributes e-cigarette liquids and vaping systems in the United States and internationally. The company also offers energy drink under the Bazi brand name. It sells its products through distributors, specialty retailers, and third-party online resellers to approximately 80 countries, primarily, including the United Kingdom, Italy, Spain, Belgium, Australia, Sweden, and Canada. The company was formerly known as True Drinks Holdings, Inc. and changed its name to Charlie's Holdings, Inc. Charlie's Holdings, Inc. was founded in 2014 and is headquartered in Costa Mesa, California.STADA Arzneimittel Aktiengesellschaft OTCMKTS:STDAF$110.42 0.00 (0.00%) As of 10/24/2022STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning These AI Stocks Have Insider Selling, But Buyers Still Have a Reason to Stay Apple’s Intel Deal Arrives at the Right Time for Its Stock Micron’s Sudden Plunge May Be an AI Buying Chance Amazon’s Pullback Deepens as a New FTC Risk Hits the Stock The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. How Does D-Wave's New Simulator Change the Quantum Computing Landscape? How Intel Is Packaging the Future of American Chips Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
